New Leaf Venture Associates II, L.P.'s Net Worth

Estimate Recalculated Dec 3, 2025 08:04PM EST

Who is New Leaf Venture Associates II, L.P.

New Leaf Venture Associates II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Principia Biopharma Inc., iRhythm Technologies, Inc., Oxford Immunotec Global PLC, Neuronetics, Inc., MEI Pharma, Inc., Durata Therapeutics, Inc., Versartis, Inc., CHIMERIX INC, ICAGEN INC, and WORLD HEART CORP.

SEC CIK

New Leaf Venture Associates II, L.P.'s CIK is 0001441858

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

iRhythm Technologies, Inc.

Investor

Updated Oct 25, 2016

View Quote Details


Form 4	69.38%	713.36K	$17.00	—	Oct 25, 2016	1.74M	Purchase	—	Oct 25
Form 3	—	—	—	—	Oct 19, 2016	—	—	—	—

Showing 2 results

Oxford Immunotec Global PLC

Investor

Updated Dec 03, 2013


Form 4	—	—	—	—	Dec 03, 2013	—	—	—	—
Form 3	—	—	—	—	Nov 21, 2013	1.38M	—	—	—

Showing 2 results

MEI Pharma, Inc.

Investor

Updated Mar 26, 2015

View Quote Details


Form 4	-100.00%	-1.60M	$1.97	-$3.16M	Mar 26, 2015	—	Sale	—	Mar 24
Form 4	-4.71%	-79.08K	$6.01	-$475.58K	Dec 10, 2014	1.60M	Sale	—	Dec 08 - Dec 09
Form 4	-17.84%	-365.00K	$8.25	-$3.01M	Nov 25, 2013	1.68M	Sale	—	Nov 21
Form 4	-8.91%	-200.00K	$8.57	-$1.71M	May 08, 2013	2.05M	Sale	—	May 06 - May 08
Form 4	-10.28%	-257.30K	$8.48	-$2.18M	Apr 22, 2013	2.25M	Sale	—	Apr 18 - Apr 19
Form 4	-16.57%	-497.23K	$6.72	-$3.34M	Feb 20, 2013	2.50M	Sale	—	Feb 15 - Feb 19
Form 3	—	—	—	—	Dec 28, 2012	3.00M	—	—	—

Showing 7 results

Durata Therapeutics, Inc.

Investor

Updated Nov 18, 2014


Form 4	-100.00%	-3.03M	—	—	Nov 18, 2014	—	Disposition	—	Nov 17
Form 4	-83.13%	-14.92M	$9.00	—	Jul 26, 2012	3.03M	Buy-Options	—	Jul 24
Form 3	—	—	—	—	Jul 18, 2012	—	—	—	—

Showing 3 results

Versartis, Inc.

Investor

Updated Dec 22, 2014

View Quote Details


Form 4	-5.86%	-150.00K	$19.01	-$2.85M	Dec 22, 2014	2.41M	Sale	—	Dec 18
Form 4	-23.81%	-800.00K	$19.37	-$15.50M	Nov 13, 2014	2.56M	Sale	—	Nov 11
Form 4	-0.37%	-12.56K	$20.02	-$251.33K	Oct 01, 2014	3.36M	Sale	—	Sep 29
Form 4	-91.32%	-35.47M	$21.02	—	Mar 28, 2014	3.37M	Buy-Options	—	Mar 27
Form 3	—	—	—	—	Mar 20, 2014	—	—	—	—

Showing 5 results

CHIMERIX INC

Investor

Updated Mar 20, 2014

View Quote Details


Form 4	-31.20%	-700.00K	—	—	Mar 20, 2014	1.54M	Disposition	—	Mar 18
Form 3/A	—	—	—	—	Mar 20, 2014	—	—	—	—

Showing 2 results

ICAGEN INC

Investor

Updated Jul 29, 2011


Form 3	—	—	—	—	Jul 29, 2011	200.50K	—	—	—

Showing 1 results

WORLD HEART CORP

Investor

Updated Aug 06, 2012


Form 4	-100.00%	-8.41M	$0.10	-$233.02K	Aug 06, 2012	—	Disposition	—	Aug 02
Form 4	125.85%	4.68M	$2.13	$10.00M	Oct 21, 2010	8.41M	Purchase	—	Oct 19
Form 4	31.30%	1.17M	$5.15	$6.00M	Jan 28, 2010	4.89M	Purchase	—	Jan 26
Form 3	—	—	—	—	Aug 08, 2008	100.00M	—	—	—

Showing 4 results

Principia Biopharma Inc.

Investor

Updated Aug 15, 2019


Form 4	-11.43%	-300.00K	$35.00	-$10.50M	Aug 15, 2019	2.33M	Sale	—	Aug 13
Form 4	11.46%	270.00K	$17.00	—	Sep 20, 2018	2.65M	Purchase	—	Sep 18
Form 3	—	—	—	—	Sep 13, 2018	—	—	—	—

Showing 3 results

Neuronetics, Inc.

Investor

Updated Jul 05, 2018

View Quote Details


Form 4	—	—	—	—	Jul 05, 2018	1.54M	Options	—	Jul 02
Form 3	—	—	—	—	Jun 27, 2018	—	—	—	—

Showing 2 results